Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience

Background Plexiform neurofibromas (PN) are the most frequent tumors associated with Neurofibromatosis type 1 (NF-1). PN can cause significant complications, including pain, functional impairment, and disfigurement. There is no efficient medical treatment and, surgical resection of large PN is frequ...

Full description

Bibliographic Details
Main Author: Espirito Santo, Vera (author)
Other Authors: Passos, Joao (author), Nzwalo, Hipólito (author), Carvalho, Ines (author), Santos, Filipa (author), Martins, Carmo (author), Salgado, Lucilia (author), Silva, Conceicao e (author), Vinhais, Sofia (author), Vilares, Miguel (author), Salgado, Duarte (author), Nunes, Sofia (author)
Format: article
Language:eng
Published: 2021
Subjects:
Selumetinib
Plexiform neurofibromas
Neurofibromatosis
Treatment
Oncology; Neurosciences & Neurology
Online Access:http://hdl.handle.net/10400.1/16563
Country:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/16563

Internet

http://hdl.handle.net/10400.1/16563

Similar Items